$GRI
GRI Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.05
▼-1.91%-$0.040
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateGRI Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is GRI down today? It is at $2.05 (-1.91%), and our scanner flagged it 40 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GRI spikes, and full due diligence on GRI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GRI 40 times in the last 30 days. Create a free account to track $GRI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on GRI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GRI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystA New Approach to Inflammatory Diseases NASDAQ: GRI | gribio.com CORPORATE PRESENTATION SEPT 2026, from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 1399.6% of the tradeable float is in play - 1399.6% more can still be issued.
Some filings did not state a size, so these are floors.
Shelf sizes are dollars, so shares are estimated at today's price.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
At-the-market (ATM) program — sells new shares into the market gradually over time · About $60.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on GRI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GRI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
GRI last traded at $2.05, down 1.91% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
GRI Bio, Inc. Common Stock (GRI) is next expected to report earnings on Friday, November 13, 2026, about 49 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The GRI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GRI 40 times in the last 30 days.
GRI (GRI Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $5M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GRI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GRI discussion
Sign in to ask a question or join the discussion.